The Journal of Pediatrics
Volume 150, Issue 2 , Pages 162-167 , February 2007

Comparative Efficacy and Cost of Asthma Care in Children with Asthma Treated with Fluticasone Propionate and Montelukast

Received 31 May 2006 ,Revised 1 August 2006 ,Accepted 26 October 2006.

References 

  1. National Asthma Education and Prevention Program, Expert Panel Report. Guidelines for the diagnosis and management of asthma update on selected topics, 2002. J Allergy Clin Immunol. 2002;110:s141–s219
  2. Global Initiative for Asthma. Global strategy for asthma management and prevention. NIH Publication 02-3659, issued January 1995, updated 2002; management segment (chap 7) updated 2005. Available at www.ginasthma.org. Accessed December 1, 2005.
  3. Wennergren G, Kristjánsson S, Stannegård IL. Decrease in hospitalizations for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol. 1996;97:742–748
  4. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled corticosteroids and the risk of hospitalization for asthma. JAMA. 1997;227:887–891
  5. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma. Thorax. 2002;57:880–884
  6. Ducharme FM, Di Salvio F. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2. 2005;Accessed January 31, 2006 through DVID
  7. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005;115:233–242
  8. Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol. 2006;117:45–52
  9. Ostrum NK, Decotis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, et al. Comparative safety and efficacy of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr. 2005;147:213–220
  10. Garcia Garcia ML, Wahl U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14- year-old patients with mild asthma: the MOSAIC study. Pediatrics. 2005;116:360–369
  11. Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Resp Med. 2001;95:227–234
  12. Stempel DA, Pinto L, Stanford RH. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist. J Allergy Clin Immunol. 2002;110:39–41
  13. Orsini L, Limpa-Amara S, Crown WH, Kamal K. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast. Ann Allergy Asthma Immunol. 2004;92:523–529
  14. Allen-Ramey FC, Duong PT, Riedel AA, Markson LE, Weiss KB. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline. Ann Allergy Asthma Immunol. 2004;93:373–380
  15. Sin DD, Man J, Sharpe H, Gan WQ, Paul Man SF. Pharmacological management to reduce exacerbations in adults with asthma. JAMA. 2004;292:367–376
  16. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma: United States, 1980-1999. MMWR. 2002;51:1–14
  17. Blais L, Ernst P, Biovin J-F, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med. 1998;158:126–132
  18. Stempel DA, McLaughlin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: a 3-year analysis of patient claims. J Allergy Clin Immunol. 2005;115:935–939
  19. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long-term prevention of hospitalization for asthma. Thorax. 2002;57:880–884
  20. Schatz M, Cook EF, Nakahiro R, Petitti D. Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma. J Allergy Clin Immun. 2003;111:503–508
  21. Lanes SF, Garcia Rodriquez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax. 2002;57:683–687
  22. Pendergraft TB, Stanford RH, Beasley R, Stempel DS, McLaughlin T. Seasonal variation in asthma-related hospital and intensive care unit admissions. J Asthma. 2005;42:265–271
  23. Johnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005;115:132–138
  24. Luskin A, Bukstein D, Sazonov Kocevar V, Yin DD. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy. Ann Allergy Asthma Immunol. 2005;95:129–136
  25. Kelly HW. Inhaled corticosteroids versus leukotriene receptor antagonists as first-line therapy for mild persistent asthma in children?. Pediatr Asthma Allergy Immunol. 2005;18:259–263
  26. Stempel DA, Meyer JW, Stanford RH, Yancey SW. One year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma. J Allergy Clin Immunol. 2001;107:94–98
  27. Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Resp Med. 2001;95:227–234
  28. Allen-Ramey FC, Anstatt DT, Sajjan SG, Markson LE. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy. Pharmacotherapy. 2005;25:1752–1760
  29. Benson K, Hartz AJ. A comparison of observational studies and randomized clinical trials. New Engl J Med. 2000;342:1887–1892
  30. Concato J, Shah N, Horowitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New Engl J Med. 2000;342:1878–1886

 Supported by GlaxoSmithKline. Dr Stempel is a consultant to GlaxoSmithKline, Dr Kruzikas is an employee of NDCHealth, and Ms Manjunath is an employee of GlaxoSmithKline. All 3 authors were involved in study design, analysis, writing, and the decision to submit this manuscript.

PII: S0022-3476(06)01038-9

doi: 10.1016/j.jpeds.2006.10.069

The Journal of Pediatrics
Volume 150, Issue 2 , Pages 162-167 , February 2007

Article Tools